Colstridium Difficile Colitis by Bloomfield, Katie
Otterbein University 
Digital Commons @ Otterbein 
Nursing Student Class Projects (Formerly MSN) Student Research & Creative Work 
Summer 7-28-2016 
Colstridium Difficile Colitis 
Katie Bloomfield 
Otterbein University, katie.bloomfield@otterbein.edu 
Follow this and additional works at: https://digitalcommons.otterbein.edu/stu_msn 
 Part of the Nursing Commons 
Recommended Citation 
Bloomfield, Katie, "Colstridium Difficile Colitis" (2016). Nursing Student Class Projects (Formerly MSN). 
156. 
https://digitalcommons.otterbein.edu/stu_msn/156 
This Project is brought to you for free and open access by the Student Research & Creative Work at Digital 
Commons @ Otterbein. It has been accepted for inclusion in Nursing Student Class Projects (Formerly MSN) by an 
authorized administrator of Digital Commons @ Otterbein. For more information, please contact 
digitalcommons07@otterbein.edu. 
Conclusion
Colstridium Difficile Colitis
Katie Bloomfield, RN, MS
Introduction
References
Aldeyab, M. A., Kearney, M. P., Scott, M.A., Motasem, A.A., Alahmadi, Y.M., 
Elhajji, F.W.,Magee, F. A., & McElnay, J.C. (2012). An evaluation of the 
impact of antibiotic stewardship on reduction the use of high risk antibiotics 
and its effect on the incidence  of clostridium difficile infection in hospital 
settings. Journal of Antimicrobial Chemotherapy, 67, 2988-2996.
http://dx.doi.org/jac/dks330.
Aldrete, S., Magee, M., Friedman-Moraco, R., Chan, A., Banks, G., Burd, E., & 
Kraft, C. (2015). Characteristics and antibiotic use associated with short-term 
risk of clostridium difficile infection among hospitalized patients. American 
Journal of Clinical Pathology, 143, 895-900.  DOI: 
10.1309/AJCP9EW16QPVTPQY.
Aziz, A. (2013).Nursing management of clostridium difficile infection. Nurse 
Prescribing, (11)1, 21-27. Retrieved from 
http://web.a.ebscohost.com/ehost/pdfviewer/pdfviewer?sid=4aff6c79-
b591-4faf- 955b-37572a962a0b%40sessionmgr4004&vid=18&hid=4107.
Banning, M. (2011). Ageing and  difficile infection the immune and 
gastrointestinal immune and gastrointestinal impact. Gastrointestinal 
Nursing, (9)4, 42-47. Retrieved from 
http://web.a.ebscohost.com/ehost/pdfviewer/pdfviewer?sid=4aff6c79-
b591-4faf-955b-37572a962a0b%40sessionmgr4004&vid=27&hid=4107
Buonomo, E. & Petri, W. (2016) The microbiota and immune response during 
Clostridium difficile infection. Anaerobe, 1-6. 
http://dx.doi.org10.1016/j.anaerobe.2016.05.009
Headley, C.M. (2012). Deadly diarrhea: clostridium difficile infection. 
Nephrology Nursing Journal, 39(6), 459-468.     Retrieved from 
http://web.a.ebscohost.com/ehost/pdfviewer/pdfviewer?sid=4aff6c79-
b591-4faf-955b-37572a962a0b%40sessionmgr4004&vid=13&hid=4107
Nazarko, L.(2015). Infection control: colstridium difficile. British Journal of 
Healthcare Assistants, (9)1,20-25. 
Walters, P.R, & Zuckerbraun, B.S. (2014).  Clostridium difficile infection clinical 
challenges and management strategies. Critical Care Nurse, (34)4, 24-35.  
http://dx.doi.org/10.4037/ccn2014822
Walters, P.R, & Zuckerbraun, B.S. (2014).  Clostridium difficile infection clinical 
challenges and management strategies: CCN fast facts. Critical Care Nurse, 
(34)4.
Wu, X., Cherian, P., Lee, R., Hurdle, J. (2013). The membrane as a target for 
controlling hypervirulent Clostridium difficile infections. Journal of 
Antimicrobial Chemotherapy(68), 806-815. Doi:10.1093/jac/dks493
Additional Sources
Colstridium Difficile Spores. Retrieved on July 24, 2016  from 
https://willeke73.files.wordpress.com/2015/03/clostridium_difficile_spore.gif?
w=237&h=137
Toxic Megacolon. Retrieved on July 24, 2016 from http://www.radpod.org/wp-
content/uploads/2007/07/toxic-megacolon.png
Significance of 
Pathophysiology
Underlying Pathophysiology
Clostridium difficile is a gram-positive anaerobe that 
produces spores and toxins.  CDI usually occurs after an 
individual’s intestinal microbiota is interrupted, usually 
following antibiotic administration.  The antibiotics destroy 
the normal microbiota, which normally functions to 
prevent infections and overgrowth, allowing the c. difficile 
bacteria to grow (Wu, et al. 2013).  C. difficile spores are 
transmitted through the fecal- oral route.  Upon entering 
the gut, the bacteria enter the mucosal layer of the 
epithelial layer and produce toxin A and toxin B, causing a 
severe inflammatory response. (Buonom & Petri, 2016).
Toxin A and toxin B “are able to glucosylate and 
inactivate Rho and Ras family small GTPases causing 
disruption of the actin cytoskeleton causing disruption of 
the actin cytoskeleton, cell rounding, inhibition of cell 
division and cell death”  (Buonom & Petri, 2016). The 
inactivation of Rho and Ras causes degranulation by the 
cytoskeleton, resulting in cell shrinkage and aptosis. 
(Walters & Zuckerbraun). This causes epithelial 
breakdown and loss of intestinal barrier, allowing for 
bacteria to enter the lamina propria, which causes 
inflammatory mediators and immune cells travel to the site. 
Neutrophils travel to the site and are found in the 
pseudomembranous lesions. Although neutrophils are the 
main cell to fight CDI, it is suspected they may also 
worsen colitis by causing damage to surrounding tissue 
(Buonom & Petri, 2016).
Clostridium difficile infection (CDI) is usually 
caused by the administration of antibiotics that causes the 
disruption of normal flora in the gut allowing for 
colonization of C difficile in the intestines (Aziz, 2013).  
CDI can cause diarrhea and may progress into colitis, 
toxic mega colon, sepsis, or even death (Headley, 2012). 
CDI has become increasingly difficult and costly to treat 
due to new hypervirulent strains, causing an increase in 
morbidity and mortality.   The average cost of treating C 
difficile is $5042 to $7179 per incident and national cost 
of $897 million to $1.3 billion a year (Walters & 
Zuckerbraun, 2014).  
Healthcare acquired infections (HAI) have become a 
national focus.  They are considered preventable and can 
be reduced with proper infection control practices, 
surveillance, and appropriate antibiotic use.  In 2009, the 
U.S Department of Health and Human Services released 
a plan to reduce all HAIs, which causes increased length 
of stay, healthcare costs, and deaths. Most of the HAIs 
have dramatically declined, but unfortunately CDIs still 
remain high (Headley, 2012). Since 2013, acute care 
hospitals have been required to report CDIs to the Center 
for Medicaid and Medicare Services (CMS), which has 
resulted in an increase awareness of infection control 
practices and feedback on their current practice, 
providing opportunities for improvement. The purpose of 
this poster is to provide information on the 
pathophysiology of CDIs and practitioners’ role in 
reducing the incidence of CDIs.
The pathophysiology  is significant because the toxins produced by C. 
Difficile causes severe inflammation in the bowel and can lead to 
pseudomembrane colitis.  The severe cases of colitis increase the risk for 
further complications, like toxic mega colon, perforated bowel and peritonitis 
(Nazarko, 2015).  These toxins can also cause a systemic effect that can lead to 
sepsis and death (Walters & Zuckerbraun, 2014).
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Implication for Nursing Care
• A patient with suspected or confirmed CDI should be immediately placed in a private 
room with enteric precautions to prevent the spread to others (Headley, 2012).
• Gloves and gown are absolutely necessary, even when in not direct contact with the 
individual. 
• Alcohol based sanitizers do not remove spores completely, so hand washing with soap 
and water  for 15 seconds must be done after removing gloves every time (Aziz, 2013).
• The infected room must be cleaned daily with a bleach solution because other cleaners 
are infective in killing the spores, which can live on surfaces for months (Headley, 2012). 
• The care provider should teach the patient and  family about infection control practices to 
reduce the risk of contracting CDI.
• The main goal is prevention and early identification of CDI.
• Antibiotic use disrupts the normal flora and sets up a perfect opportunity for  CDI.
• The appropriate and discriminate use of antibiotics is paramount to prevention (Walters & 
Zuckerbarun, 2014).
• Vancomycin intravenous administration within the previous eight weeks increase the risk 
of CDI (Aldrete, et al., 2015).
• Patients at an increase risk should be identified and monitored  closely for symptoms. 
Some risk factors include:
 Age > 65 years old
 Recent antibiotic use
 Hospitalization
 Comorbidities
 Nasogastric tubes
 Proton pump inhibitors (Narako, 2015)
• A stool specimen should be obtained and sent for a PCR test, if there are 2 or more loose 
stools in 24 hours.
• Monitor for further complications of CDI, like toxic megacolon, perforated bowel,  
peritonitis, or sepsis.
Clostridium difficile infection have been 
increasing and is the most common health care 
acquired infections (Bunomo & Petri, 2016). C 
difficile colitis can lead to many complications that are 
very costly and lead to significant increase in length of 
stay.  There are many opportunities in the acute care 
setting to reduce the rate of health care acquired CDI.  
As with many bacteria, C Difficile is becoming more 
resistant to treatment. The inappropriate and over 
use of antibiotics is a major reason why there has 
been an increase in the cases and resistance of c 
difficile to treatment.   This should be addressed 
daily with each patient to determine if they are 
receiving the right antibiotics based off cultures 
and symptoms. The need for quick identification and 
diagnosis is key to prevent further complications and  
strict infection control practices to prevent the further 
spread.
Symptoms
C. difficile colitis can have  a wide range of symptoms that varies in the severity
Symptoms can occur during antibiotic therapy  or up to 10 weeks after completing antibiotic 
treatment.
May be asymptomatic 
Abdominal pain and tenderness
watery diarrhea lasting greater than 48 hours
Elevated white blood cell count
Fever
Dehydration
Hypotension
Tachycardia
Loss of appetite
Mental Status changes
Lactic acidosis
Figure 1 Toxic megacolon xray
Figure 2 Colstridium difficile spores
